Back to Home
Home >> Biosafety >>Biosafety Biological Containments
Back to Home

Biosafety Biological Containments - Biological containments specifically aims at making such genetic changes in GMOs that reduce the hazard from these organisms when they are accidentally released from laboratories or accidentally transported by workers. Initially, NIH guidelines required the use of E. coli strains and vectors that were severely debilitated, viz., that could not infect humans, did not survive and spread outside the laboratory, and could not transfer the introduced foreign genes readily into other organisms in the environment.

These objectives can be achieved by using the following:

(1) auxotrophic mutants of E. coli (limits survival following escape of bacteria),

(2) recA strains (they lack recombination function),

(3) plasmid vectors that are non selftransmissible and non-mobilizable (such vectors can not be transmitted to other bacteria), and

(4) E. coli strains not carrying a transposon or antibiotic resistance gene.

Thus biological containment is based on the vector (plasmid, organelle or virus) used for the construction of recombinant DNA, and the host (bacterial, plant, or animal cell) in which the vector is propagated in the laboratory; therefore it is also called HV system (host-vector system).

Any combination of vector and host, which is to provide biological containment shall be chosen or constructed so that the following types of scapes' are minimized:

(i) survival of the vector in its host outside the laboratory, and

(ii) transmission of the vector from the propagation host to other non laboratory hosts.